Collectively, these findings underscore that FoxO signaling does not act in isolation but rather serves as a molecular hub, integrating multiple upstream regulators (e.g., DDIT4) and intersecting with inflammatory pathways (e.g., STAT3), thereby contributing to the shared pathogenesis of osteoporosis and sarcopenia. This evidence concerns the gene STAT3 and sarcopenia.